LONG-TERM CULTURES OF CHRONIC LYMPHOCYTIC-LEUKEMIA B-CELLS GENERATE B-SUPPRESSOR CELLS

被引:6
作者
FARKAS, R
MANOR, Y
KLAJMAN, A
机构
[1] MEIR HOSP, CLIN IMMUNOL LAB, KFAR SABA, ISRAEL
[2] MEIR HOSP, MED DEPT B, KFAR SABA, ISRAEL
[3] TEL AVIV UNIV, SACKLER SCH MED, TEL AVIV, ISRAEL
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1987年 / 42卷 / 02期
关键词
D O I
10.1016/0090-1229(87)90004-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B suppressor cells (Bs) were generated by stimulation with PHA-P or concanavalin A of B cells from peripheral blood of B-cell chronic lymphocytic leukemia (B-CLL) patients. They suppressed well allogeneic mixed lymphocyte reactions. Long-term colonies of B cells from B-CLL were established for up to 6 weeks in liquid media, with B cells acquiring properties of suppressor cells while being cultured. Two types of cultures were observed: cells either grew in compact multicellular colonies or formed diffuse monolayers. Cells that remained alive in cultures for a number of weeks, but did not multiply, did not develop suppressive characteristics. Bs cells retained their phenotypic markers in cultures. Mitosis and lymphoblasts, but no differentiation into plasma cells, were observed. PHA-P-generated Bs were cultured in long-term cultures of B-CLL cells may facilitate a better understanding of the nature and characteristics of normal and leukemic B cells.
引用
收藏
页码:171 / 182
页数:12
相关论文
共 34 条
[1]  
BACIGALUPO A, 1980, J IMMUNOL, V125, P1449
[2]   CELL-TO-CELL INTERACTION IN IMMUNE-RESPONSE .10. T-CELL-DEPENDENT SUPPRESSION IN TOLERANT MICE [J].
BASTEN, A ;
MILLER, JFAP ;
SPRENT, J ;
CHEERS, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1974, 140 (01) :199-217
[3]  
BECKER MJ, 1981, CLIN EXP IMMUNOL, V45, P439
[4]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P31
[5]  
FARKAS R, IMMUNOLOGY
[6]  
GILBERT KM, 1982, IMMUNOLOGY, V46, P545
[7]  
GILLIS S, 1978, J IMMUNOL, V120, P2027
[8]  
KABELITZ D, 1985, J IMMUNOL, V135, P2876
[9]  
KIRCHNER H., 1976, MITOGENS IMMUNOBIOLO, P495
[10]  
KOENING JT, 1976, SCAND J IMMUNOL, V5, P771